It's time to compare anemia management strategies in hemodialysis.
Coyne
Daniel W
DW
Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8129, St. Louis, MO 63110, USA. DCoyne@im.wustl.edu
D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D015415:Biomarkers / Q000097:blood; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004920:Erythropoiesis / Q000187:drug effects; D019317:Evidence-Based Medicine; D006397:Hematinics / Q000008:administration & dosage* / Q000009:adverse effects; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D058085:Iron Compounds / Q000008:administration & dosage* / Q000009:adverse effects; D007674:Kidney Diseases / Q000097:blood / Q000150:complications / Q000401:mortality / Q000628:therapy*; D006435:Renal Dialysis; D018570:Risk Assessment; D016896:Treatment Outcome
D015415:Biomarkers; D006397:Hematinics; D006454:Hemoglobins; D058085:Iron Compounds